Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2026-05-20 @ 6:07 PM
Study NCT ID:
NCT06668493
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2024-10-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Sponsor:
Ferring Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Low-grade Upper Tract Urothelial Carcinoma | View |
Keywords: